Literature DB >> 17889967

Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation.

Anna Bersano1, Roberto Del Bo, Costanza Lamperti, Serena Ghezzi, Gigliola Fagiolari, Francesco Fortunato, Elena Ballabio, Maurizio Moggio, Livia Candelise, Daniela Galimberti, Roberta Virgilio, Silvia Lanfranconi, Yvan Torrente, Marinella Carpo, Nereo Bresolin, Giacomo P Comi, Stefania Corti.   

Abstract

Hereditary inclusion body myopathy (IBM) with Paget's disease of the bone (PDB) and frontotemporal dementia (FTD) is a rare autosomal dominant disease caused by mutations in the valosin-containing protein (VCP) gene. We report a novel heterozygous VCP gene mutation (R159C) in a 69-year-old Italian patient presenting with slowly progressive muscle weakness of the distal upper and proximal lower limbs since the age of 50 years, 18 years later FTD supervened. No dementia or myopathies were revealed in the family history covering two generations. Degenerative changes and rimmed vacuoles together with VCP- and ubiquitin-positive cytoplasmic and nuclear aggregates were observed at the muscle biopsy. Several elements support the pathogenic role of the R159C VCP gene mutation: the occurrence at the same codon of a different, previously identified pathogenic mutation within a VCP gene mutational hot-spot, the histopathological and biochemical evidence of muscle VCP accumulation and the combined clinical presentation of IBM and FTD. These findings suggest VCP gene investigation even in apparently sporadic cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889967     DOI: 10.1016/j.neurobiolaging.2007.08.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  29 in total

Review 1.  MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.

Authors:  Paola Rinchetti; Mafalda Rizzuti; Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 2.  A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.

Authors:  Samuel Katsuyuki Shinjo; Sueli Mieko Oba-Shinjo; Antonio Marcondes Lerario; Suely Kazue Nagahashi Marie
Journal:  Clin Rheumatol       Date:  2017-11-10       Impact factor: 2.980

3.  Clinical, pathological, and genetic mutation analysis of sporadic inclusion body myositis in Japanese people.

Authors:  Huaying Cai; Ichiro Yabe; Kazunori Sato; Takahiro Kano; Masakazu Nakamura; Hideki Hozen; Hidenao Sasaki
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

4.  Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy.

Authors:  E Al-Obeidi; S Al-Tahan; A Surampalli; N Goyal; A K Wang; A Hermann; M Omizo; C Smith; T Mozaffar; V Kimonis
Journal:  Clin Genet       Date:  2018-01       Impact factor: 4.438

5.  Targeted excision of VCP R155H mutation by Cre-LoxP technology as a promising therapeutic strategy for valosin-containing protein disease.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Christopher Nguyen; Edward S Monuki; Virginia E Kimonis
Journal:  Hum Gene Ther Methods       Date:  2015-02       Impact factor: 2.396

6.  VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

Authors:  Michael A Gitcho; Jeffrey Strider; Deborah Carter; Lisa Taylor-Reinwald; Mark S Forman; Alison M Goate; Nigel J Cairns
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

7.  Phenotypic variability in three families with valosin-containing protein mutation.

Authors:  S Spina; A D Van Laar; J R Murrell; R L Hamilton; J K Kofler; F Epperson; M R Farlow; O L Lopez; J Quinlan; S T DeKosky; B Ghetti
Journal:  Eur J Neurol       Date:  2012-08-20       Impact factor: 6.089

8.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

9.  Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis.

Authors:  Paloma González-Pérez; Elizabeth T Cirulli; Vivian E Drory; Ron Dabby; Puiu Nisipeanu; Ralph L Carasso; Menachem Sadeh; Andrew Fox; Barry W Festoff; Peter C Sapp; Diane McKenna-Yasek; David B Goldstein; Robert H Brown; Sergiu C Blumen
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

10.  215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands.

Authors:  Teresinha Evangelista; Conrad C Weihl; Virginia Kimonis; Hanns Lochmüller
Journal:  Neuromuscul Disord       Date:  2016-05-30       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.